{"entity":{"type":"insider","cik":"0001352453","url":"/insider/0001352453","json_url":"/insider/0001352453.json","name":"Blight Andrew","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":425,"n_filings":42,"first":"2006-11-08","last":"2017-02-13","span_basis":"filed_date"},"name_variants":[{"name":"Blight Andrew","source":"filing","n_filings":42,"first_seen":"2006-11-08","last_seen":"2017-02-13"}],"transactions":[{"id":5250997,"accession":"0001209191-17-009966","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-009966","line_url":"/filing/0001209191-17-009966#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67586.0,"shares_display":"67,586","price_per_share":22.4067,"price_display":"22.41","price_state":"stated","total_value":1514379.2262,"total_display":"1,514,379.23","total_whole":"1,514,379","shares_owned_after":76558.0,"shares_owned_after_display":"76,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-09","filed_date":"2017-02-13","scope":"insider"},{"id":3004640,"accession":"0001209191-16-153395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-153395","line_url":"/filing/0001209191-16-153395#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4855.0,"shares_display":"4,855","price_per_share":20.7568,"price_display":"20.76","price_state":"stated","total_value":100774.264,"total_display":"100,774.26","total_whole":"100,774","shares_owned_after":76558.0,"shares_owned_after_display":"76,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-05","scope":"insider"},{"id":8813096,"accession":"0001209191-15-081690","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-081690","line_url":"/filing/0001209191-15-081690#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":37.47,"price_display":"37.47","price_state":"stated","total_value":18735.0,"total_display":"18,735.00","total_whole":"18,735","shares_owned_after":71659.0,"shares_owned_after_display":"71,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-20","filed_date":"2015-11-23","scope":"insider"},{"id":8094959,"accession":"0001209191-15-076350","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-076350","line_url":"/filing/0001209191-15-076350","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientifc Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientifc Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientifc Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32500.0,"shares_display":"32,500","price_per_share":30.865124615384616,"price_display":"30.87","price_state":"stated","total_value":1003116.55,"total_display":"1,003,116.55","total_whole":"1,003,117","shares_owned_after":75359.0,"shares_owned_after_display":"75,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-19","filed_date":"2015-10-21","scope":"insider","n_lines":2},{"id":8145326,"accession":"0001209191-15-071986","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-071986","line_url":"/filing/0001209191-15-071986","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientifc Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientifc Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientifc Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13085.0,"shares_display":"13,085","price_per_share":31.303948437141766,"price_display":"31.30","price_state":"stated","total_value":409612.1653,"total_display":"409,612.17","total_whole":"409,612","shares_owned_after":77850.0,"shares_owned_after_display":"77,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-21","filed_date":"2015-09-23","scope":"insider","n_lines":2},{"id":6741488,"accession":"0001209191-14-064289","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-064289","line_url":"/filing/0001209191-14-064289#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientifc Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientifc Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientifc Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52338.0,"shares_display":"52,338","price_per_share":32.0759,"price_display":"32.08","price_state":"stated","total_value":1678788.4542,"total_display":"1,678,788.45","total_whole":"1,678,788","shares_owned_after":65787.0,"shares_owned_after_display":"65,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-20","filed_date":"2014-10-22","scope":"insider"},{"id":4461873,"accession":"0001209191-13-055358","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-055358","line_url":"/filing/0001209191-13-055358#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientifc Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientifc Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientifc Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9088.0,"shares_display":"9,088","price_per_share":33.5127,"price_display":"33.51","price_state":"stated","total_value":304563.4176,"total_display":"304,563.42","total_whole":"304,563","shares_owned_after":59787.0,"shares_owned_after_display":"59,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-04","scope":"insider"},{"id":4304952,"accession":"0001209191-13-037568","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-037568","line_url":"/filing/0001209191-13-037568#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientifc Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientifc Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientifc Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19296.0,"shares_display":"19,296","price_per_share":37.82,"price_display":"37.82","price_state":"stated","total_value":729774.72,"total_display":"729,774.72","total_whole":"729,775","shares_owned_after":68875.0,"shares_owned_after_display":"68,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-19","filed_date":"2013-07-23","scope":"insider"},{"id":3130909,"accession":"0001209191-12-055909","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-055909","line_url":"/filing/0001209191-12-055909#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientifc Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientifc Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientifc Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7200.0,"shares_display":"7,200","price_per_share":24.2005,"price_display":"24.20","price_state":"stated","total_value":174243.6,"total_display":"174,243.60","total_whole":"174,244","shares_owned_after":61325.0,"shares_owned_after_display":"61,325","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-03","filed_date":"2012-12-05","scope":"insider"},{"id":2581735,"accession":"0001209191-12-050371","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-050371","line_url":"/filing/0001209191-12-050371#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientifc Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientifc Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientifc Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9481.0,"shares_display":"9,481","price_per_share":23.08,"price_display":"23.08","price_state":"stated","total_value":218821.48,"total_display":"218,821.48","total_whole":"218,821","shares_owned_after":68525.0,"shares_owned_after_display":"68,525","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-22","filed_date":"2012-10-24","scope":"insider"},{"id":8998178,"accession":"0001209191-11-059451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-059451","line_url":"/filing/0001209191-11-059451#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientifc Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientifc Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientifc Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":22.92,"price_display":"22.92","price_state":"stated","total_value":160440.0,"total_display":"160,440.00","total_whole":"160,440","shares_owned_after":54725.0,"shares_owned_after_display":"54,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-01","filed_date":"2011-12-05","scope":"insider"},{"id":7290731,"accession":"0001209191-10-014012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-014012","line_url":"/filing/0001209191-10-014012#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientifc Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientifc Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientifc Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4173.0,"shares_display":"4,173","price_per_share":32.2087,"price_display":"32.21","price_state":"stated","total_value":134406.9051,"total_display":"134,406.91","total_whole":"134,407","shares_owned_after":32108.0,"shares_owned_after_display":"32,108","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-02","filed_date":"2010-03-03","scope":"insider"},{"id":7749413,"accession":"0001209191-10-006555","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-006555","line_url":"/filing/0001209191-10-006555#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientifc Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientifc Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientifc Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4534.0,"shares_display":"4,534","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":136020.0,"total_display":"136,020.00","total_whole":"136,020","shares_owned_after":36281.0,"shares_owned_after_display":"36,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-02","filed_date":"2010-02-03","scope":"insider"},{"id":5666040,"accession":"0001209191-09-055039","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-055039","line_url":"/filing/0001209191-09-055039#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientifc Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientifc Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientifc Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":24.5056,"price_display":"24.51","price_state":"stated","total_value":110275.2,"total_display":"110,275.20","total_whole":"110,275","shares_owned_after":40815.0,"shares_owned_after_display":"40,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-01","filed_date":"2009-12-02","scope":"insider"},{"id":3841062,"accession":"0001179110-08-012226","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-08-012226","line_url":"/filing/0001179110-08-012226","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":31.715,"price_display":"31.72","price_state":"stated","total_value":57087.0,"total_display":"57,087.00","total_whole":"57,087","shares_owned_after":29815.0,"shares_owned_after_display":"29,815","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-12","filed_date":"2008-06-16","scope":"insider","n_lines":5},{"id":3514299,"accession":"0001179110-08-012223","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001179110-08-012223","line_url":"/filing/0001179110-08-012223","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9200.0,"shares_display":"9,200","price_per_share":30.656184782608694,"price_display":"30.66","price_state":"stated","total_value":282036.9,"total_display":"282,036.90","total_whole":"282,037","shares_owned_after":56315.0,"shares_owned_after_display":"56,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-12","filed_date":"2008-06-16","scope":"insider","n_lines":27},{"id":3406637,"accession":"0001179110-08-012225","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001179110-08-012225","line_url":"/filing/0001179110-08-012225#line-28","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":31.52,"price_display":"31.52","price_state":"stated","total_value":37824.0,"total_display":"37,824.00","total_whole":"37,824","shares_owned_after":34015.0,"shares_owned_after_display":"34,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-12","filed_date":"2008-06-16","scope":"insider"},{"id":3406636,"accession":"0001179110-08-012225","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001179110-08-012225","line_url":"/filing/0001179110-08-012225#line-27","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001352453","owner_name":"Blight Andrew","owner_display_name":"Blight Andrew","owner_url":"/insider/0001352453","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":31.47,"price_display":"31.47","price_state":"stated","total_value":31470.0,"total_display":"31,470.00","total_whole":"31,470","shares_owned_after":35515.0,"shares_owned_after_display":"35,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-06-12","filed_date":"2008-06-16","scope":"insider"}],"collapsed":true,"next_cursor":"2008-06-12|3406636","ledger_fault":false,"count":{"value":425,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":425,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":425},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001008848","name":"ACORDA THERAPEUTICS INC","url":"/issuer/0001008848","role":"Officer (Chief Scientific Officer)","n_filings":42,"first_seen":"2006-11-08","last_seen":"2017-02-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001352453","retrieved_at":"2026-08-23T03:05:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}